CD274 and neoplasm: A study by Jiang et al showed that high expression of TYRO3 could induce tumor cell resistance to anti-PD-1/PD-L1 therapy by upregulating genes that block ferroptosis and downregulating genes inducing ferroptosis, thus inhibiting ferroptosis.